We are live on ! Find out more
MD icon

Pediatrix Medical

391 hedge funds and large institutions have $6.68B invested in Pediatrix Medical in 2016 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 147 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $2.55M

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

41% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 32

10% more capital invested

Capital invested by funds: $6.05B → $6.68B (+$624M)

2% more funds holding

Funds holding: 382391 (+9)

10% more repeat investments, than reductions

Existing positions increased: 147 | Existing positions reduced: 134

0.63% more ownership

Funds ownership: 98.62%99.25% (+0.63%)

Holders
391
Holders Change
+9
Holders Change %
+2.36%
% of All Funds
10.41%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
45
Increased
147
Reduced
134
Closed
32
Calls
$6.11M
Puts
$2.55M
Net Calls
+$3.55M
Net Calls Change
-$3.05M

MD Hedge Fund Activity: Q2 2016 in Review

391 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2016, worth a combined $6.68B — up 10% from $6.05B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new MD positions and 32 closed out — a net gain of 13 holders — while 147 added to existing stakes and 134 trimmed.

The largest buyer was Nordea Investment Management, adding an estimated $147M. The largest seller was Bank of New York Mellon, cutting an estimated $81.8M.

  • 391 institutional investors held Pediatrix Medical (MD) as of Q2 2016, up from 382 in Q1 2016.
  • Funds reported $6.68B of Pediatrix Medical stock for Q2 2016, up 10% quarter-over-quarter.
  • 45 funds opened new Pediatrix Medical positions in Q2 2016 and 32 closed out, a net change of +13 holders.
  • The largest Pediatrix Medical buyer in Q2 2016 was Nordea Investment Management, an estimated $147M added.
  • The largest Pediatrix Medical seller in Q2 2016 was Bank of New York Mellon, an estimated $81.8M sold.

Based on aggregated 13F filings for Q2 2016.